Objective To provide data support for the clinical rational use of infectious disease hospital drug supervision. Methods The antibacterials use in the hospital from 2011 to 2014 was analyzed in terms of consump-tion sum, usage, AUD and DDDs. Results The antibacterial drug use indicators showed a downward trend. The consumption sum percentage decreased from 17. 71 to 10 around, the usage of inpatients decreased from 69. 37 to 60 around, and AUD also had a certain degree of decline. The consumption sum of piperacillin sodium / tazobactam so-dium was maintained top 2, and anti-fungal drug voriconazole capsules ranked in the top 10 during 3 years. 3 anti-fungal drugs for AIDS patients were always in the top 10 antibacterials DDDs from 2011 to 2014. Conclusion Through the antimicrobial activities of special remediation, the use of antibacterials has been controlled effectively. However, antibacterial use characteristics of infectious disease hospital require attention by the relevant decision-making departments and formulate control target in accordance with the characteristics of infectious disease hospital.%目的 为传染病医院抗菌药物临床合理应用监管提供数据支持.方法 对该院2011-2014年抗菌药物使用金额、使用率、抗菌药物使用强度(AUD)、用药频度(DDDs)等进行统计、分析.结果 抗菌药物使用的各项指标呈下降趋势,抗菌药物金额所占百分比由17.71%下降至10%左右,住院患者抗菌药物使用率从69.37%下降至60%左右,AUD也有一定程度下降.药品金额排序中哌拉西林钠/他唑巴坦钠连续3年均排名前2位,抗真菌药伏立康唑胶囊连续3年进入前10位.DDDs排名前10位的药物中每年均有3种药物是艾滋病人常用于抗真菌的药物.结论 通过抗菌药物专项整治活动,该院的抗菌药物使用得到了有效控制,但传染病医院的抗菌药物使用特点需引起决策部门的重视,制定符合传染病医院特点的控制目标.
展开▼
